[Cardiovascular PAPPS 2005: a critical analysis]
- PMID: 17428425
- PMCID: PMC7664551
- DOI: 10.1157/13100844
[Cardiovascular PAPPS 2005: a critical analysis]
Comment in
-
[Response of the Cardiovascular PAHPP Group to the critical analysis of the 2005 recomendations].Aten Primaria. 2008 Jan;40(1):49-50. doi: 10.1157/13114329. Aten Primaria. 2008. PMID: 18190772 Free PMC article. Spanish. No abstract available.
References
-
- Villar-Álvarez F., Villar-Álvarez F., Maiques-Galán A., Brotons-Cuixart C., Torcal-Laguna J., Banegas-Banegas J.J. Recomendaciones preventivas cardiovasculares en atención primaria. PAPPS. Aten Primaria. 2005;36(Supl 2):11–26.
-
- De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J. Executive summary. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003;24:1601–1610. - PubMed
-
- Comité Español Interdisciplinario para la Prevención Cardiovascular. Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Madrid: Ministerio de Sanidad y Consumo; 2004.
-
- ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensinconverting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA. 2002;288:2981–2997. - PubMed
-
- Psaty B.M., Lumley T., Furbey C.D., Schellenbaum G., Pahor M., Alderman M.H. Health outcomes associated with various antihypertensive therapies used as first-line agents. JAMA. 2003;289:2534–2544. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
